|
gptkbp:instance_of
|
gptkb:Company
|
|
gptkbp:application
|
antibiotic resistance
|
|
gptkbp:awards
|
2020 Best Places to Work
|
|
gptkbp:business_model
|
biopharmaceuticals
|
|
gptkbp:ceo
|
gptkb:Maria_Zuber
|
|
gptkbp:clinical_trial
|
Phase 1
genetic disorders
safety and efficacy
infectious diseases
bacterial diseases
infectious disease treatments
|
|
gptkbp:collaborations
|
gptkb:Duke_University
gptkb:Research_Institute
academic institutions
academic collaborations
research partnerships
global institutions
|
|
gptkbp:community
|
biotech researchers
|
|
gptkbp:community_engagement
|
healthcare awareness
|
|
gptkbp:developer
|
gene therapies
|
|
gptkbp:focus
|
gptkb:CRISPR_technology
|
|
gptkbp:founded
|
gptkb:2015
|
|
gptkbp:founder
|
gptkb:Paul_Garofolo
|
|
gptkbp:future_plans
|
novel therapies
expanding research
|
|
gptkbp:goal
|
developing precision medicines
|
|
gptkbp:headquarters
|
gptkb:Research_Triangle_Park,_North_Carolina
|
|
gptkbp:healthcare
|
precision medicine
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Locus Biosciences
|
|
gptkbp:impact
|
public health
|
|
gptkbp:innovation
|
CRISPR applications
gene editing technologies
CRISPR innovations
CRISPR-based solutions
|
|
gptkbp:invention
|
CRISPR-based therapies
patents and licenses
|
|
gptkbp:investment
|
gptkb:Google_Ventures
|
|
gptkbp:leadership
|
biotech industry
|
|
gptkbp:market
|
healthcare
|
|
gptkbp:marketing_strategy
|
collaborative research
biotech sector
|
|
gptkbp:objective
|
improving health outcomes
|
|
gptkbp:partnership
|
gptkb:University_of_North_Carolina
|
|
gptkbp:partnerships
|
pharmaceutical companies
|
|
gptkbp:platform
|
gptkb:CRISPR-Cas3
|
|
gptkbp:products
|
therapeutic solutions
Locus-2
|
|
gptkbp:publishes
|
peer-reviewed journals
|
|
gptkbp:receives_funding_from
|
gptkb:Company
gptkb:National_Science_Foundation
$100 million
|
|
gptkbp:regulatory_compliance
|
gptkb:FDA
|
|
gptkbp:research
|
gptkb:CRISPR_technology
gene editing advancements
|
|
gptkbp:research_areas
|
microbiome
|
|
gptkbp:research_focus
|
scientists and engineers
therapeutics
CRISPR technology applications
antimicrobial therapies
|
|
gptkbp:side_effect
|
disease management
|
|
gptkbp:sustainability_initiatives
|
innovative treatments
|
|
gptkbp:tactics
|
targeted gene editing
|
|
gptkbp:targets
|
bacterial infections
|
|
gptkbp:technology
|
genetic engineering
gene editing
|
|
gptkbp:vision
|
transforming medicine
|
|
gptkbp:website
|
locusbiosciences.com
|
|
gptkbp:bfsParent
|
gptkb:23and_Me
|
|
gptkbp:bfsLayer
|
4
|